Cargando…

Correction to: Lectin‐Like Oxidized Low‐Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 Results

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111530/ https://www.ncbi.nlm.nih.gov/pubmed/36892068 http://dx.doi.org/10.1161/JAHA.122.027644

Ejemplares similares

Lectin‐Like Oxidized Low‐Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 Results
por: Vavere, Andrea L., et al.
Publicado: (2023)

Inhibition of the lectin-like oxidized low-density lipoprotein receptor-1 improves intestinal microcirculation in experimental endotoxaemia
por: Lehmann, C, et al.
Publicado: (2009)

Lectin-like oxidized low-density lipoprotein receptor 1 attenuates pneumonia-induced lung injury
por: Korkmaz, Filiz T., et al.
Publicado: (2022)

Role of Lectin-Like Oxidized Low Density Lipoprotein-1 in Fetoplacental Vascular Dysfunction in Preeclampsia
por: Zuniga, Felipe A., et al.
Publicado: (2014)

Soluble Lectin-Like Oxidized Low Density Lipoprotein Receptor-1 as a Biochemical Marker for Atherosclerosis-Related Diseases
por: Pirillo, Angela, et al.
Publicado: (2013)

Increased Levels of Lectin‐Like Oxidized Low‐Density Lipoprotein Receptor‐1 in Ischemic Stroke and Transient Ischemic Attack
por: Skarpengland, Tonje, et al.
Publicado: (2018)

Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 Is Inversely Correlated with the Activity of ANCA-Associated Vasculitis
por: Yoon, Taejun, et al.
Publicado: (2020)

Inhibition of lectin-like oxidized low-density lipoprotein receptor-1 reduces leukocyte adhesion within the intestinal microcirculation in experimental endotoxemia in rats
por: Landsberger, Martin, et al.
Publicado: (2010)

Proteolytic Regulation of the Lectin-Like Oxidized Lipoprotein Receptor LOX-1
por: Mentrup, Torben, et al.
Publicado: (2021)

Association between soluble lectin-like oxidized low-density lipoprotein receptor 1 levels and coronary slow flow phenomenon
por: Caglar, Ilker Murat, et al.
Publicado: (2016)

Lectin-like, oxidized low-density lipoprotein receptor-1-deficient mice show resistance to age-related knee osteoarthritis
por: Hashimoto, Kazuhiko, et al.
Publicado: (2017)

Clinical analysis of lectin-like oxidized low-density lipoprotein receptor-1 in patients with in-stent restenosis after percutaneous coronary intervention
por: Liu, Junfeng, et al.
Publicado: (2018)

Plasma soluble lectin-like oxidized low-density lipoprotein receptor-1 acts as a new biomarker for NSTEMI and STEMI patients
por: Sheikh, Md Sayed Ali
Publicado: (2022)

Serum Soluble Lectin-like Oxidized Low-Density Lipoprotein Receptor-1 (sLOX-1) Is Associated with Atherosclerosis Severity in Coronary Artery Disease
por: Kott, Katharine A., et al.
Publicado: (2023)

Serum Lectin-Like Oxidized-Low Density Lipoprotein Receptor-1 and Adiponectin Levels Are Associated With Coronary Artery Disease Accompanied With Metabolic Syndrome
por: Md Sayed, Ali Sheikh, et al.
Publicado: (2014)

Correction: Lipopolysaccharide Is Cleared from the Circulation by Hepatocytes via the Low Density Lipoprotein Receptor
por: Topchiy, Elena, et al.
Publicado: (2016)

Pregnancy Followed by Delivery May Affect Circulating Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Levels in Women of Reproductive Age
por: Balin, Mehmet, et al.
Publicado: (2012)

High Levels of Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Acute Stroke: An Age- and Sex-Matched Cross-Sectional Study
por: Yokota, Chiaki, et al.
Publicado: (2016)

Serum soluble lectin‐like oxidized low‐density lipoprotein receptor‐1 as a biomarker of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage
por: Lin, Qun, et al.
Publicado: (2020)

Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Level is Related to Clinical Prognosis In Patients with Acute Atherosclerosis-related Ischemic Stroke
por: Yang, Xiaoli, et al.
Publicado: (2021)

Role of Plasma Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 and microRNA-98 in Severity and Risk of Coronary Artery Disease
por: Sheikh, Md Sayed Ali
Publicado: (2021)

Chronic Aerobic Exercise Decreases Lectin-Like Low Density Lipoprotein (LOX-1) Receptor Expression in Heart of Diabetic Rat
por: Riahi, Simin, et al.
Publicado: (2016)

Circulating Soluble Lectin-like Oxidized Low-Density Lipoprotein Receptor-1 (sLOX-1): A Diagnostic Indicator across the Spectrum of Acute Coronary Syndrome
por: Kumar, Sandeep, et al.
Publicado: (2021)

Serum Levels of Carbamylated LDL and Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Are Associated with Coronary Artery Disease in Patients with Metabolic Syndrome
por: Stankova, Teodora, et al.
Publicado: (2019)

Effect of oral magnesium sulfate administration on lectin‐like oxidized low‐density lipoprotein receptor‐1 gene expression to prevent atherosclerosis in diabetic rat vessels
por: Fazlali, Mina, et al.
Publicado: (2018)

Association of circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 with inflammatory markers and urinary albumin excretion in patients with type 2 diabetes
por: Takebayashi, Kohzo, et al.
Publicado: (2021)

High Plasma Levels of Soluble Lectin‐like Oxidized Low‐Density Lipoprotein Receptor‐1 Are Associated With Inflammation and Cardiometabolic Risk Profiles in Pediatric Overweight and Obesity
por: Stinson, Sara E., et al.
Publicado: (2023)

Association of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 With Angiotensin II Type 1 Receptor Impacts Mitochondrial Quality Control, Offering Promise for the Treatment of Vascular Senescence
por: Uchikado, Yoshihiro, et al.
Publicado: (2021)

Association between angiopoietin-like protein 2 and lectin-like oxidized low-density lipoprotein receptor 1 ligand containing apolipoprotein B in patients with type 2 diabetes
por: Suzuki, Tatsuhiko, et al.
Publicado: (2018)

Author Correction: Proteolysis of the low density lipoprotein receptor by bone morphogenetic protein-1 regulates cellular cholesterol uptake
por: Banerjee, Sreemoti, et al.
Publicado: (2020)

A bovine papillomavirus-1 based vector restores the function of the low-density lipoprotein receptor in the receptor-deficient CHO-ldlA7 cell line: Correction
por: Tammur, Jaana, et al.
Publicado: (2002)

Correction: Protective effects of paraoxonase-1, vitamin E and selenium, and oxidative stress index on the susceptibility of low density lipoprotein to oxidation in diabetic patients with/without coronary artery disease
por: Mehvari, Fatemeh, et al.
Publicado: (2023)

Correction: Larrea divaricata: anti-inflammatory and antioxidant effects on macrophages and low density lipoproteins
por: Peralta, Ignacio, et al.
Publicado: (2022)

Smoking cessation reduces the lectin-like low-density lipoprotein receptor index, an independent cardiovascular risk marker of vascular inflammation
por: Komiyama, Maki, et al.
Publicado: (2017)

Correction to: Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin
por: Hayashi, Toshiyuki, et al.
Publicado: (2017)

Knockdown of lectin-like oxidized low-density lipoprotein-1 ameliorates alcoholic cardiomyopathy via inactivating the p38 mitogen-activated protein kinase pathway
por: Zhang, Yifan, et al.
Publicado: (2022)

“Benifuuki” Extract Reduces Serum Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Ligands Containing Apolipoprotein B: A Double-Blind Placebo-Controlled Randomized Trial
por: Miyawaki, Masahiro, et al.
Publicado: (2018)

Higher serum lectin-like oxidized low-density lipoprotein receptor-1 in patients with stable coronary artery disease is associated with major adverse cardiovascular events: A multicentre pilot study
por: Zhao, Zi-wen, et al.
Publicado: (2019)

Correction: High Density Lipoprotein Stimulated Migration of Macrophages Depends on the Scavenger Receptor Class B, Type I, PDZK1 and Akt1 and Is Blocked by Sphingosine 1 Phosphate Receptor Antagonists
Publicado: (2015)

Correction: Delphinidin-3-Glucoside Protects against Oxidized Low-Density Lipoprotein-Induced Mitochondrial Dysfunction in Vascular Endothelial Cells via the Sodium-Dependent Glucose Transporter SGLT1
por: Jin, Xin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gvfb0gfi591tj1hqmvjj8g12j1